Recent advances in biomimetic nanodelivery systems: new brain-targeting strategies

J Liao, L Fan, Y Li, QQ Xu, LY Xiong, SS Zhang… - Journal of Controlled …, 2023 - Elsevier
In recent years, brain diseases have seriously threatened human health due to their high
morbidity and mortality. Achieving efficient drug delivery to provide satisfactory therapeutic …

[HTML][HTML] Recent advances in nanomedicines for the treatment of ischemic stroke

C Li, T Sun, C Jiang - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Ischemic stroke is a cerebrovascular disease normally caused by interrupted blood supply to
the brain. Ischemia would initiate the cascade reaction consisted of multiple biochemical …

From adsorption to covalent bonding: Apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood–brain barrier

N Hartl, F Adams, OM Merkel - Advanced therapeutics, 2021 - Wiley Online Library
The blood–brain barrier (BBB) is composed of brain endothelial cells, pericytes, and
astrocytes, which build a tight cellular barrier. Therapeutic (macro) molecules are not able to …

Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier

G Tosi, JT Duskey, J Kreuter - Expert opinion on drug delivery, 2020 - Taylor & Francis
Introduction: Current therapies of neurodegenerative or neurometabolic diseases are, to a
large extent, hampered by the inability of drugs to cross the blood-brain barrier (BBB). This …

Advanced drug delivery system against ischemic stroke

S Zhang, Y Zhou, R Li, Z Chen, X Fan - Journal of Controlled Release, 2022 - Elsevier
Ischemic stroke is a vascular central nervous system (CNS) disease that leads a disability
and death. Thrombolysis and neuroprotection are the primary treatment strategies of …

Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs

E Karami, M Behdani, F Kazemi-Lomedasht - Journal of Drug Delivery …, 2020 - Elsevier
Given that albumin has important roles in human body, it can be used in the field of medicine
and disease treatment. In recent years, albumin is used as a carries in disease diagnosis …

Nanomedicines-tiny particles and big challenges

MRC Marques, Q Choo, M Ashtikar, TC Rocha… - Advanced Drug Delivery …, 2019 - Elsevier
After decades of research, nanotechnology has been used in a broad array of biomedical
products including medical devices, drug products, drug substances, and pharmaceutical …

Nerve growth factor biodelivery: a limiting step in moving toward extensive clinical application?

G Alastra, L Aloe, VA Baldassarro, L Calzà… - Frontiers in …, 2021 - frontiersin.org
Nerve growth factor (NGF) was the first-discovered member of the neurotrophin family, a
class of bioactive molecules which exerts powerful biological effects on the CNS and other …

Exploring the interplay between drug release and targeting of lipid-like polymer nanoparticles loaded with doxorubicin

T Kovshova, N Osipova, A Alekseeva, J Malinovskaya… - Molecules, 2021 - mdpi.com
Targeted delivery of doxorubicin still poses a challenge with regards to the quantities
reaching the target site as well as the specificity of the uptake. In the present approach, two …

Injectable drug delivery systems of doxorubicin revisited: In vitro-in vivo relationships using human clinical data

H Modh, DJ Fang, YH Ou, JNN Yau, T Kovshova… - International Journal of …, 2021 - Elsevier
A growing number of nanomedicines entered the clinical trials and improved our
understanding of the in vivo responses expected in humans. The in vitro drug release …